Details of the Drug-Related molecule(s) Activity Atlas
General Information of Drug (ID: DMVIMQX)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
ZSTK474; 475110-96-4; ZSTK-474; 4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine; ZSTK 474; TCMDC-137004; UNII-K0068GK39A; CHEMBL586702; CHEBI:90545; K0068GK39A; 2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine; 2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-bis(morpholino)-1,3,5-triazine; AK-40326; 2-(Difluoromethyl)-1-(4,6-Dimorpholin-4-Yl-1,3,5-Triazin-2-Yl)-1h-Benzimidazole; C19H21F2N7O2; 2wxl; PubChem22461; SCHEMBL373282; QCR-72; GTPL7965; CTK8B6247; SYN1099
|
|||||
| Therapeutic Class |
Anticancer Agents
|
|||||
| Cross-matching ID | ||||||
Molecule-level Activity Landscape of This Drug
|
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Experimental Drug Sensitivity Data Across Cancer Cell Lines
|
|
||||||||||||||||
|
||||||||||||||||
Cytotoxic Activity Landscape of This Drug
|
||||||||||||||||
